INKT logo

INKT

MiNK Therapeutics, Inc.NASDAQHealthcare
$10.69+7.02%ClosedMarket Cap: $50.2M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-04-01HC Wainwright & Co.maintainBuyBuy
2025-08-15HC Wainwright & Co.upgradeBuyNeutral
2025-07-15HC Wainwright & Co.downgradeNeutralBuy
2025-07-14William BlairdowngradeMarket PerformOutperform
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Thu Dec 31$-3.61$125.0K1
Fri Dec 31$-3.85$4.4M1
Sun Dec 31$-1.52$33.0M2
Mon Dec 31$0.49$62.4M1